Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Headshot of Scott Galbari, Lyniate, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Adopting Robust Solutions to Achieve Compliance With Interoperability Requirements
10/04/2022
Scott Galbari, chief operating officer, Lyniate, shares challenges payers and providers have faced while trying to meet interoperability requirements and offers advice for organizations hoping to adopt new technologies to ease the process.
Scott Galbari, chief operating officer, Lyniate, shares challenges payers and providers have faced while trying to meet interoperability requirements and offers advice for organizations hoping to adopt new technologies to ease the process.
Scott Galbari, chief operating...
10/04/2022
Integrated Healthcare Executive

Advertisement

Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network
Headshot of Daniel A Vorobiof, Belong.Life, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Personalized Platform Offers Community, Resources for Patients With CML
08/30/2022
Daniel A Vorobiof, MD, chief medical officer, Belong.Life, discusses the Belong.Life app's resources for patients with cancer as well as the recent addition of personalized tools for those with chronic myeloid leukemia.
Daniel A Vorobiof, MD, chief medical officer, Belong.Life, discusses the Belong.Life app's resources for patients with cancer as well as the recent addition of personalized tools for those with chronic myeloid leukemia.
Daniel A Vorobiof, MD, chief...
08/30/2022
Integrated Healthcare Executive

Advertisement

Headshot of Tanja Dowe, Debiopharm Innovation Fund SA, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Addressing Inefficiencies in Drug Development With AI
08/23/2022
Tanja Dowe, CEO, Debiopharm Innovation Fund SA, discusses the partnership between Debiopharm and VeriSIM Life and how advancements in technology can speed up the drug development process.
Tanja Dowe, CEO, Debiopharm Innovation Fund SA, discusses the partnership between Debiopharm and VeriSIM Life and how advancements in technology can speed up the drug development process.
Tanja Dowe, CEO, Debiopharm...
08/23/2022
Integrated Healthcare Executive
Headshot of John Murray, Stryker, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Implementing Robotic Assisted Technology for Joint Replacement Surgeries in Veterans
08/11/2022
John Murray, senior director of government accounts, Stryker, discusses how placing innovative surgical technology in Veterans Affairs hospitals can improve care quality for veterans with arthritis.
John Murray, senior director of government accounts, Stryker, discusses how placing innovative surgical technology in Veterans Affairs hospitals can improve care quality for veterans with arthritis.
John Murray, senior director of...
08/11/2022
Veterans Health Today

Advertisement

Headshot of Adam Kittai, Ohio State University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Second Generation BTK Inhibitors: Reviewing Data on CLL Treatments
06/30/2022
Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, shares how second generation BTK inhibitors are changing treatment decisions in chronic lymphocytic leukemia, and adds what payers should keep in mind...
Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, shares how second generation BTK inhibitors are changing treatment decisions in chronic lymphocytic leukemia, and adds what payers should keep in mind...
Adam Kittai, MD, hematologist...
06/30/2022
First Report Managed Care
Petros Grivas, MD, Fred Hutchinson Cancer Center
Podcasts
Sacituzumab Govitecan Plus Pembrolizumab Yields Encouraging Response Rates in Metastatic Urothelial Cancer
06/22/2022
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares...
06/22/2022
Oncology
Robert Jones, MD
Podcasts
Maintenance Therapy With Cabozantinib Shows No Significant Benefit vs Placebo for Metastatic Urothelial Carcinoma
06/21/2022
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results...
06/21/2022
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

What's Trending?

Diagnosing Sarcoidosis: Endosonography versus Bronchoscopy
08/14/2013
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a...
08/14/2013
First Report Managed Care
News
Students Welcomed to Live in Nursing Facilities
02/14/2017
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing...
02/14/2017
Annals of Long-Term Care
News
FDA Panel Votes Against Approval of GSK Lung Disease Drug
07/25/2018
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did...
07/25/2018
Pharmacy Learning Network
News
Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Seniors and Younger Patients with Hand Osteoarthritis
03/04/2015
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual...
03/04/2015
Annals of Long-Term Care
News
Test Designed to Screen Resistance to Cancer Drug
07/29/2010
07/29/2010
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use